Skip To Main Content
Campus
  • Terapiområde
Campus
  • Terapiområde
View Full Results
Sort by

Filtera

Återställ
  • Filtera
  • Innehållstyp

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Läs mer

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

Läs mer

Inside Global Fabry Academy (GFA) 2025

Läs mer

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

Läs mer

Om BALANS i Region Stockholm

Läs mer

Bullous Pemphigoid: A Clinical & Scientific Update

Läs mer

EVEREST study: First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.

Läs mer

CIRCLIQ® On-Body Injector

Läs mer

Understanding Disease Modification in Atopic Dermatitis

Läs mer

EFLUELDA - Seasonal high dose flu vaccine

Läs mer

FLUNITY-HD: Results of the pooled analysis of the two individually randomized real-world studies, DANFLU 2 and GALFLU

Monday September 15th, 2025 16:00-17:15 CET

Läs mer

Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk

People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.1 The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.2,3

Läs mer